Cell Culture Market Size to Attain USD 63.6 Billion by 2032

Published Date : 13 Mar 2024

The global cell culture market size exceeded USD 26.54 billion in 2023 and is estimated to attain around USD 63.6 billion by 2032, poised to grow at a CAGR of 10.20% during the forecast period from 2023 to 2032.

Cell Culture Market Size and Growth Rate From 2023 to 2032

Market Overview

A cell is the elemental unit of life and is essential for taking out vital operations. Different types of cells perform various functions depending on the needs and demands of the organism. It is called cell culture, when cells are extracted from a living plant or animal and grown or produced in a favorable artificial environment. In other words, cell culture can be defined as cultivating cells in artificial environments outside of living organisms. Cell culture allows for the analysis of biological and physiological functions in living organisms, providing functional understandings of their life cycles for researchers and the scientific community in the cell culture market.

However, increased experience is essential for improving drug efficacy, developing new products, and advancing preventative care to enhance global public health. Scientists use cell culture to study the body's metabolic and basic cell biology through model systems. Additionally, cell culture is utilized in the production of vaccines. Cell culture is the process of growing cells outside their natural habitat, which sustains them under controlled conditions. The global market for cell culture is expected to grow significantly due to various factors, including the increasing awareness of the benefits of cell-based vaccines, the rising incidence of chronic diseases, and the surging demand for monoclonal antibodies. The growing demand for 3D cell culture techniques in the biopharmaceutical industry drives the cell culture market.

Regional Snapshot

North America dominated the global cell culture market in 2023. The growth of the market has been fueled by increasing investments in research studies on the mechanisms. Further, the North American market has experienced significant growth due to the surging demand for personalized medicine in the US and the presence of many leading market participants in the region. The market in North America has experienced rapid growth due to the supportive policies of the National government towards medical research, given that healthcare is a significant industry in the US. A new cell line will be developed for scientific studies within three years. The North American cell culture industry has experienced rapid growth due to the existence of leading biopharmaceutical organizations, multiple agreement analyses, and manufacturing communities.

Asia Pacific is expected to be the fastest-growing region during the forecast period. The Asia Pacific cell culture market is witnessing significant growth due to the increasing presence of top biopharmaceutical companies and contract research organizations in South Korea, India, China, and Japan. The market is expected to grow in the coming years due to the rising number of drug discovery activities and the increasing demand for cell culture techniques among research laboratories and academic research institutions.

Cell Culture Market Report Scope

Report Coverage Details
Market Revenue in 2023 USD 26.54 Billion
Projected Forecast Revenue by 2032 USD 63.6 Billion
Growth Rate from 2023 to 2032 CAGR of 10.20%
Largest Market North America
Base Year 2022
Forecast Period 2023 to 2032
Regions Covered North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa

Market Dynamics


Increasing technological advancements

The demand for advancements in cell culture technology is increasing due to the advances in proteomic gene expression and biopharmaceutical development. The global cell culture market is experiencing growth thanks to the rise in cancer research projects, the improved application of gene therapies, and the increasing prevalence of cancer. Many contract manufacturing and research firms contribute positively to developing the cell culture industry. The growing incidence of chronic diseases worldwide has led to investments in cytology and biology analysis studies.

Increasing demand for biological research

The cell culture market is experiencing a surge in demand due to the growing need for biological research in various sectors, including pharmaceuticals, biotechnology, and medical research. The development of new drugs, the study of diseases, and the exploration of regenerative medicine all rely heavily on cell culture techniques. As research advances in these areas, the demand for cell culture products and services is expected to grow, driven by the need for high-quality cell cultures for experimental purposes.


Cell culture is costly

Cell extraction and development is an extremely delicate process that requires a highly controlled environment with optimal conditions for the cells to develop. Maintaining a sterile environment throughout the process is essential to avoid contamination of cell samples, which can result in significant losses of capital, time, and effort. Additionally, the culture of cells is performed by highly qualified and skilled professionals, and the entire process involves a combination of labor, capital, infrastructure, time, and other production factors, making it a costly process. As an outcome, the expensive nature of cell culture significantly restricts the market's growth.


Technological innovations

The cell culture market is characterized by continuous technological advancements that improve cell culture processes' efficiency, accuracy, and reliability. This includes the development of new cell culture media, using advanced imaging techniques to monitor cell growth, and introducing of automated cell culture systems. These technological advancements enhance cell culture quality and open new market differentiation avenues. This area's ongoing research and development will create more opportunities in the coming years.

Introducing 3D cell culture technologies significantly advances the cell culture market. These technologies mimic the natural microenvironment of cells in three dimensions, providing a more physiologically relevant platform for cell growth, differentiation, and study. This approach improves the accuracy of cell behavior studies. It has applications in drug discovery, disease modeling, and regenerative medicine.3D cell culture technologies offer improved cell viability and function compared to traditional 2D culture methods. This is due to the more complex and dynamic nature of the 3D environment, which better mimics the conditions of cells. This improvement enhances cell culture quality for research purposes and opens new avenues for developing biopharmaceuticals and regenerative therapies.

  • In June 2023, for instance, 3D BioFibR entered the bioprinting and 3D cell culture market by launching Two CollaFibR™ Tissue Engineering Products.
  • In June 2023, eNUVIO announced the release of the first completely reusable 3D cell culture microplate on the market. Scientific research currently consumes high volumes of single-use plastics—from serological pipettes and pipette tips to vials and culture microplates—these are just a few of the many plastic items thrown in the garbage in labs daily.

Recent Developments

  • In November 2023, Lonza launched a new cell line, and MilliporeSigma introduced a digital reference materials platform.
  • In August 2023, Sartorius and Repligen launched an integrated bioreactor system incorporating Repligen XCell® ATF upstream intensification technology into Sartorius’ Biostat STR® bioreactor. According to both companies, the goal is to simplify intensified seed train and N perfusion implementation for biopharmaceutical manufacturers.
  • In February 2022, Nucleus Biologics, the cell performance company, announced the launch of Krakatoa. This innovative, first-to-market media maker allows researchers to manufacture cell culture media at the point of use. Moving media manufacturing to the benchtop addresses sustainability and improves media quality.

Key Market Players

  • Corning Incorporated
  • Merck KGaA
  • Sartorius AG 
  • BioSpherix, Ltd.
  • Cell Culture Company, LLC 
  • Thermo Fisher Scientific Inc.
  • VWR International LLC 
  • Lonza
  • Eppendorf AG
  • FUJIFILM Irvine Scientific, Inc.

Market Segmentation

By Product

  • Equipment
    • Centrifuges
    • Culture Systems/Bioreactors
    • Biosafety Equipment
    • Cryostorage Equipment
    • Pipetting Instruments
    • Incubators
    • Cell Culture Vessels
    • Others
  • Consumables
    • Reagents
    • Growth Factors & Cytokines
    • Albumin
    • Protease inhibitor
    • Thrombin
    • Attachment Factors
    • Amino Acids
  • Sera
    • Fetal Bovine Serum (FBS)
    • Others
  • Media
    • Chemically Defined
    • Classical Media
    • Lysogeny Broth
    • Serum Free
    • Protein Free
    • Specialty Media

By Application

  • Drug Discovery
  • Biopharmaceuticals
    • Monoclonal antibodies
    • Vaccines production
    • Other therapeutic proteins
  • Tissue Culture and Engineering
    • Cell and gene therapy
    • Other tissue engineering & regenerative medicine applications
  • Vaccine Production
  • Gene Therapy
  • Others

By End User

  • Pharmaceutical & Biotechnology Companies
  • Hospitals & Diagnostic Laboratories
  • Research & Academic Institutes
  • Other

Buy this Research Report@ https://www.precedenceresearch.com/checkout/1803

You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com | +1 650 460 3308